61016-62-4

Upstream product

• 66015-52-9 2-(4-methoxyphenyl)-2-methyl-5-hydroxy-6,7-dichloro-1-indanone 
• 53107-36-1 1-(2,3-dichloro-4-methoxyphenyl)-2-bromo-2-methyl-1-propanone 
• 67976-23-2 2-(4-methoxyphenyl)-2-methyl-5-benzyloxy-6,7-dichloro-1-indanone 
• 66015-39-2 5-(benzyloxy)-6,7-dichloro-2-methyl-1-indanone 
• 66015-56-3 2-methyl-5-hydroxy-6,7-dichloro-1-indanone 
• 53107-37-2 1-(2,3-dichloro-4-methoxyphenyl)-2-methylene-1-propanone 
• 53107-35-0 2',3',-Dichloro-4'-methoxyisobutyrophenone 
• 1984-59-4 2,3-dichloroanisole 
• 54196-91-7 6,7-dichloro-5-methoxy-2-methyl-1-indanone 
• 66015-27-8 [1-oxo-2-(4-methoxyphenyl)-2-methyl-6,7-dichloro-5-indanyloxy]acetic acid 

Relevant academic research and scientific papers

(1-Oxo-2-aryl or thienyl-2-substituted-5-indanyloxy (or thio) alkanoic acids, and derivatives thereof

[1-Oxo-2-aryl or thienyl-2-substituted-5-indanyloxy (or thio)]aklanoic acid, derivatives thereof, their salts, esters and amides are disclosed. The products display a dual pharmaceutical utility in that they exhibit diuretic, saluretic and uricosuric activity. Also disclosed are processes for the preparation of such [1-oxo-2-aryl or thienyl-2-substituted-5-indanyloxy (or thio)]alkanoic acids, pharmaceutical compositions comprising therapeutically effective amounts of such compounds and methods of treatment comprising administering such compounds and compositions.